Glaucoma Risk Assessment Package

This image shows an elderly woman having her intraocular pressure measured with an applanation tonometry, an essential diagnostic tool correlated with a glaucoma risk assessment package.

PHP 11082

OVERVIEW

The Glaucoma Risk Assessment Package combines optic disc photos, visual field testing, and OCT optic nerve head scans. It checks both nerve structure and visual function. This non-invasive package helps detect early glaucoma risk and supports accurate monitoring and treatment planning.

TERMS AND CONDITIONS, INCLUSIONS, AND EXCLUSIONS

1. Package includes disc photography, visual field test, and OCT optic nerve head scan only. 2. Professional interpretation by the ophthalmologist is required. 3. Package supports risk assessment and does not confirm diagnosis alone. 4. Fees may vary with repeat tests or additional imaging. 5. Test reliability depends on patient cooperation and fixation. 6. Some patients may require dilation or repeat scans. 7. Treatment and medications are not included.

CONTACT INFORMATION

Dr. Manolette Roque | Dr. Barbara Roque St. Luke’s Medical Center – Global City 2nd Floor, Units 217-218, Roque Eye Clinic, Medical Arts Building Rizal Drive cor. 5th Ave, Taguig City 1634, Philippines +63-917-844-2020 +63-998-998-2020 +63-2-8828-2020 +63-2-8789-7700 ext. 7217 +63-2-8789-7700 ext. 7218

Dr. Manolette Roque | Dr. Barbara Roque St. Luke’s Medical Center – Global City 2nd Floor, Tan Eng Gee Eye Institute, Main Hospital Building Rizal Drive cor. 5th Ave, Taguig City 1634, Philippines +63-998-582-1980 +63-2-8789-7700 ext. 2020 +63-2-8789-7700 ext. 2024

The Glaucoma Risk Assessment Package is a comprehensive diagnostic service that checks for early signs of glaucoma and optic nerve damage. It combines advanced imaging and functional tests to measure eye pressure risk factors, nerve structure, and visual performance. As a result, your ophthalmologist can detect problems earlier and guide timely treatment.

WHAT THIS PACKAGE INCLUDES

This package uses four validated, evidence-based tests that work together. Each test measures a different part of glaucoma risk. Therefore, results are more reliable when interpreted as a group.

1. Humphrey automated visual field test to map your side vision and detect functional loss.
2. Optical coherence tomography of the optic nerve head to measure nerve fiber thickness.
3. Pachymetry to measure corneal thickness, which affects eye pressure interpretation.
4. Optic disc photography to document nerve appearance for baseline comparison.

WHY EARLY GLAUCOMA TESTING MATTERS

Glaucoma often develops without early symptoms. However, silent nerve damage can progress before vision changes are noticed. Because of this, structured risk assessment plays a key role in prevention. Early detection allows closer monitoring and earlier treatment, which helps protect long-term vision.

WHO SHOULD CONSIDER THIS SERVICE

Your doctor may recommend this package if you have known risk factors. For example, testing is useful for people with elevated eye pressure, suspicious optic nerves, or a family history of glaucoma. In addition, patients over age forty or those with diabetes, high myopia, or long-term steroid use benefit from baseline evaluation.

HOW THE TESTS ARE PERFORMED

These tests are non-surgical and clinic-based. First, trained staff guide you through the visual field test using a response button and light targets. Next, OCT and optic disc photos are captured using high-resolution scanners and cameras. Then, pachymetry measures corneal thickness using a quick probe or noncontact device. Most visits finish within one hour.

PATIENT SAFETY AND COMFORT

The procedures are safe and widely used in modern ophthalmology. You may experience brief light sensitivity or mild fatigue during visual field testing. Otherwise, most patients complete the package comfortably. Your ophthalmologist reviews all findings and explains the results clearly.

CLINICAL VALUE OF A COMBINED PACKAGE

Each test answers a different clinical question. Together, they provide a stronger glaucoma risk profile than any single test alone. Consequently, your care plan becomes more precise, personalized, and evidence-based. This combined approach supports better long-term monitoring and decision-making.